Sialic acids in cancer biology and immunity
The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Abstract
During malignant transformation, glycosylation is heavily altered compared with healthy tissue due to differential expression of glycosyltransferases, glycosidases and monosaccharide transporters within the cancer microenvironment. One key change of malignant tissue glycosylation is the alteration of sialic acid processing that leads to a general upregulation of sialylated glycans (hypersialylation) on cell surfaces and an increased introduction of the non-human sialic acid N-glycolyl-neuraminic acid (Neu5Gc) instead of N-acetyl-neuraminic acid into cell surface glycans. These changes have been shown to be the result of altered sialyltransferase and sialidase expression. Functionally, cancer-associated hypersialylation appears to directly impact tumor cell interaction with the microenvironment, in particular the modulation of sialic acid-binding lectins on immune cells. Moreover, Neu5Gc expression in human tissues enhances inflammation due to an anti-Neu5Gc immune response, which can potentially influence inflammation-induced cancer and cancer-associated inflammation. In this review, we summarize the changes of sialic acid biology within the malignant microenvironment and the resulting effect on cancer immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies over the past decades have suggested a clear function of sialoglycans in tumors via immune evasion, not only by shielding of antigens but also by sialic acids show robust immunomodulatory properties as sugar moieties [260, 262, 263].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [263]
Citations
Cites
Items 201–232 of 232
Nomura, H., Tamada, Y., Miyagi, T., Suzuki, A., Taira, M., Suzuki, N., Susumu, N., Irimura, T., & Aoki, D. (2006) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/000000006783981035 · Cited by 42
Hata, K., Tochigi, T., Sato, I., Kawamura, S., Shiozaki, K., Wada, T., Takahashi, K., Moriya, S., Yamaguchi, K., Hosono, M., et al. (2015) · Cancer Science · doi:10.1111/cas.12627 · Cited by 42
E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis
Yasmin-Karim, S., King, M. R., Messing, E. M., & Lee, Y.-F. (2014) · Oncotarget · doi:10.18632/oncotarget.2503 · Cited by 42
Human-Specific Evolutionary Changes in the Biology of Siglecs
Schwarz, F., Fong, J. J., & Varki, A. P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-11280-0_1 · Cited by 41
Takahashi, K., Hosono, M., Sato, I., Hata, K., Wada, T., Yamaguchi, K., Nitta, K., Shima, H., & Miyagi, T. (2015) · International Journal of Cancer · doi:10.1002/ijc.29527 · Cited by 40
Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
Hoos, A., Protsyuk, D., & Borsig, L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0946 · Cited by 38
Cloning and Expression of cDNA for a Human Siaα2,3Galβ1,4GlcNA:α2,8-Sialyltransferase (hST8Sia III)
Lee, Y., Kim, Y., Lee, K., Kim, K.-S., Kim, B.-U., Kim, H. N., Kim, C., & Do, S.-I. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0909 · Cited by 37
Glycolipids Support E-Selectin-Specific Strong Cell Tethering under Flow
Burdick, M. M., Bochner, B. S., Collins, B. E., Schnaar, R. L., & Konstantopoulos, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4899 · Cited by 37
Miyata, M., Kambe, M., Tajima, O., Moriya, S., Sawaki, H., Hotta, H., Kondo, Y., Narimatsu, H., Miyagi, T., Furukawa, K., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02086.x · Cited by 36
Schauer, R. (1970) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1970.351.1.749 · Cited by 34
Molecular subtyping of metastatic melanoma based on cell ganglioside metabolism profiles
Tringali, C., Silvestri, I., Testa, F., Baldassari, P., Anastasia, L., Mortarini, R., Anichini, A., López‐Requena, A., Tettamanti, G., & Venerando, B. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-560 · Cited by 33
Hypoxia-enhanced expression of free deaminoneuraminic acid in human cancer cells
Go, S., Sato, C., Yin, J., Kannagi, R., & Kitajima, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.181 · Cited by 32
Go, S., Sato, C., Furuhata, K., & Kitajima, K. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-6734-z · Cited by 29
Cabezas, J. A. (1991) · Biochemical Journal · doi:10.1042/bj2780311 · Cited by 28
Heparins Attenuate Cancer Metastasis: Are Selectins the Link?
Laubli, H. P., & Borsig, L. (2009) · Cancer Investigation · doi:10.1080/07357900802647136 · Cited by 27
Bonardi, D., Papini, N., Pasini, M., Dileo, L., Orizio, F., Monti, E., Caimi, L., Venerando, B., & Bresciani, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099405 · Cited by 27
Gottschling, S., Jensen, K., Warth, A., Herth, F. J. F., Thomas, M., Schnabel, P. A., & Herpel, E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00225711 · Cited by 27
Tringali, C., Cirillo, F., Lamorte, G., Papini, N., Anastasia, L., Lupo, B., Silvestri, I., Tettamanti, G., & Venerando, B. (2012) · International Journal of Cancer · doi:10.1002/ijc.27450 · Cited by 25
Pal, S., Bandyopadhyay, S., Chatterjee, M., Bhattacharya, D. K., Minto, L., Hall, A. G., & Mandal, C. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.01.001 · Cited by 23
Inoue, S., Poongodi, G. L., Suresh, N., Chang, T., & Inoue, Y. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-6125-5 · Cited by 22
Effects of a human plasma membrane-associated sialidase siRNA on prostate cancer invasion
Li, X., Zhang, L., Shao, Y., Liang, Z., Shao, C., Wang, B., Guo, B., Li, N., Zhao, X., Li, Y., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.001 · Cited by 20
Yamamoto, K., Takahashi, K., Shiozaki, K., Yamaguchi, K., Moriya, S., Hosono, M., Shima, H., & Miyagi, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120578 · Cited by 20
Hormesis in cancer immunology: Does the quantity of an immune reactant matter?
Pearce, O. M. T., Laubli, H. P., Bui, J. D., & Varki, A. P. (2014) · OncoImmunology · doi:10.4161/onci.29312 · Cited by 19
Self-citationSchauer, R. (1970) · PubMed · Cited by 16
MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas
Housseau, F., Zeliszewski, D., Roy, M., Paradis, V., Richon, S., Ricour, A., Bougaran, J., Prapotnich, D., Vallancien, G., Benoît, G., et al. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<556::aid-ijc9>3.0.co;2-t · Cited by 15
Biological Roles of Glycans -- Essentials of Glycobiology
Varki, A. P., Rd, C., Jd, E., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Me, E. (2009) · Cited by 15
Basu, S. S., Basu, M., Li, Z., & Basu, S. C. (1996) · Biochemistry · doi:10.1021/bi960239l · Cited by 14
Wu, X., Ragupathi, G., Panageas, K. S., Hong, F., & Livingston, P. O. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0088 · Cited by 14
Chen, W., Xiang, J. Y., Chen, D., Ni, B., Chen, H., Fan, X., Wang, P.-N., Song, S., Fang, L., Xiao, H.-Y., et al. (2013) · Molecular Biology Reports · doi:10.1007/s11033-012-2338-9 · Cited by 12
Berger, J., Yaneva, H., & Antoine, B. (1970) · PubMed · Cited by 8
Successful engineering cancer immunotherapy
Romero, P. J., & Coukos, G. (2014) · European Journal of Immunology · doi:10.1002/eji.201444472 · Cited by 2
Cited by
Ligand-installed nanocarriers toward precision therapy
Mi, P., Cabral, H., & Kataoka, K. (2020) · Advanced Materials · doi:10.1002/adma.201902604 · Cited by 350
Carbohydrate-Based Macromolecular Biomaterials
Su, L., Feng, Y., Wei, K., Xu, X., Liu, R., & Chen, G. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01338 · Cited by 335
Exploration of the Sialic Acid World
(2018) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/bs.accb.2018.09.001 · Cited by 320
Tumor microenvironment signaling and therapeutics in cancer progression
Goenka, A., Khan, F., Verma, B., Sinha, P., Dmello, C. C., Jogalekar, M. P., Gangadaran, P., & Ahn, B. (2023) · Cancer Communications · doi:10.1002/cac2.12416 · Cited by 323
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
Stanczak, M. A., Siddiqui, S. S., Trefny, M. P., Thommen, D. S., Boligan, K. F., von Gunten, S., Tzankov, A., Tietze, L., Lardinois, D., Heinzelmann-Schwarz, V., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120612 · Cited by 296
“patterns’ (SAMPs) by binding to CD33-related sialic acid-binding immunoglobulin-like lectins (CD33rSiglecs) (8, 9), a family of receptors on immune cells containing intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIM) (10-13).”
Metadata
- Authors
- Pearce, O. M. T., & Läubli, H.
- Affiliations
- Queen Mary University of London (GB)
- ORCID
- Pearce, Oliver M T
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-30
- Volume
- 26
- Issue
- 2
- Pages
- 111-128
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W1938656015
- Cited by
- 470
- References
- 231
- Citations by year
- 2026: 32 · 2025: 42 · 2024: 46 · 2023: 64 · 2022: 50 · 2021: 60 · 2020: 53 · 2019: 44 · 2018: 42 · 2017: 24 · 2016: 12 · 2015: 1
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Glycobiology (publishedVersion)
- PubMed (publishedVersion)
- RERO DOC (Universität Bern) (submittedVersion)
- Funders
- University of Basel (Liechtenstein Foundation)
- Huggenberger-Bischoff Foundation
- Cancer Research, Schoenemakers-Mueller Foundation
- Promedica Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- sialic acid, hypersialylation, N-glycolylneuraminic acid, sialyltransferase, neuraminidase, tumor microenvironment, sialic acid-binding lectins, immune cells, tumor inflammation, antitumor immunity, glycosylation alterations
- MeSH terms
- Animals, Humans, Sialic Acids, Immune Evasion, Tumor Microenvironment, Sialic Acid Binding Immunoglobulin-like Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.